This training will provide you with a sense of security in medical practice, which will help you grow personally and professionally”

Tumors affecting children are different from those of adults, both in clinical behavior, treatments and diagnosis. Skills and abilities are required to help children live and coexist with the disease from a clinical and healthy point of view. 

Oncology professionals, especially in the field of childhood cancer, need to be aware of the most pioneering advances that can be used in the treatment of children in order to provide them with a quality of life.  

This postgraduate diploma in Childhood and Juvenile Cancer offers the possibility of specializing in the treatment of cancer in children and young people in order to acquire the excellent professional skills to treat specific diseases that occur at very early ages. 

The training will allow the development of competencies, skills and abilities for the performance of the profession, taking into account that the patients are children who require different attention and treatment than adults. 

This program is supported by a teaching staff made up of prestigious professionals in the specialized oncology field who have prepared each module with a deep analysis and scientific rigor, through their own professional experiences, the most outstanding advances and the most effective treatments.  A great opportunity to specialize in Childhood and Juvenile Cancer with great professionals in the sector.  

Update your knowledge with this postgraduate diploma in Childhood and Juvenile Cancer"

This postgraduate diploma in Childhood and Juvenile Cancer contains the most complete and up-to-date scientific program on the market. The most important features include:

• Development of more than 75 case studies presented by experts in Child and Adolescent Cancer
• The graphic, schematic, and eminently practical contents with which they are created provide scientific and practical information on the disciplines that are essential for professional practice
• News on Childhood and Juvenile Cancer
• It contains practical exercises where the self-evaluation process can be carried out to improve learning
• Special emphasis on innovative methodologies in Childhood and Juvenile Cancer. All this will be complemented with theoretical lessons, questions to the expert, discussion forums on controversial issues and individual reflection work
• Availability of content from any fixed or portable device with internet connection 

This postgraduate diploma may be the best investment you can make in the selection of a refresher program for two reasons: in addition to updating your knowledge in Childhood and Juvenile Cancer you will obtain a postgraduate diploma issued by TECH Technological University"

It includes in its teaching staff professionals belonging to the field of Childhood and Juvenile Cancer who pour into this training the experience of their work, in addition to recognized specialists belonging to reference societies and prestigious universities.

The multimedia content developed with the latest educational technology will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive training program to train in real situations.

This program is designed around Problem Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the course. For this purpose, the professional will be assisted by an innovative interactive video system developed by renowned experts in the field of Childhood and Juvenile Cancer and with great medical experience. 

Enhance your professional performance and improve your patients' quality of life"

Take the opportunity to learn about the latest advances in Childhood and Juvenile Cancer and improve the health of your patients"

The online postgraduate diploma in Childhood and Juvenile Cancer is aimed at facilitating the performance of the professional dedicated to aesthetic medicine with the latest advances and newest treatments in the sector. 

This postgraduate diploma is designed for you to update your knowledge in Childhood and Juvenile Cancer, with the use of the latest medical technology and scientific advances to contribute to promote the health and quality of life of patients"

General Objective

• The main goal of this training in Childhood and Juvenile Cancer is to provide the professional with a deep scientific knowledge of oncology, especially addressing the tumors that most affect children and young people, as well as the most advanced treatments and advances

Specific Objectives

• Recognize the characteristics of malignant neoplasms, their classification according a their histogenesis, as well as aspects related to their biological behavior
• Acquire up-to-date knowledge on cancer epidemiological data worldwide
• Learn about screening methods in at-risk populations to diagnose cancerous lesions early
• Recognize the environmental and occupational factors (mutagenic agents) that are directly and indirectly involved in cancer, and the carcinogenic capacity of some toxic substances found in food
• Relate DNA and RNA viruses known to cause cancer in humans
• Expose the mechanisms by which viruses are able to subjugate the normal activity of host cytoplasmic proteins, affecting key points in the control of the cell cycle, cell growth and differentiation, causing severe alterations in cell growth and cancer development
• Recognize the role of H. pylori bacteria in the pathogenesis of gastric cancer
• Understand cancer as a genetic disease resulting from mutations that accumulate in genes that are critical for the growth and development of somatic cells
• Describe the genes associated with cancer, and the importance of DNA analysis to identify individuals, detect predisposing gene polymorphisms, analyze mutations, and establish the diagnosis of cancer as a genetic disease
• Recognize the susceptibility genes involved in breast, lung, thyroid, colon, skin, bone, pancreatic, and neuroblastoma cancers, and by what mechanism they participate in tumorigenesis
• Know the symptoms and signs that are most frequently related to cancer, as well as the different systems for the staging of tumor disease and their importance
• Know the phases of the cell cycle, the critical control points, as well as the genes involved in its regulation
• Recognize the important role of cell cycle checkpoints and DNA repair systems in maintaining the fidelity and integrity of genome replication and repair, and regulating cell cycle dynamics
• Explain the positive and negative feedback regulatory processes that contribute to cell cycle progression, and the significance of negative controls on cell cycle progression that are present during development, differentiation, senescence, and cell death, which play an important role in preventing tumorigenesis
• Identify the difference in gene expression between normal tissue and tumor tissue
• Know the stages involved in the transformation of a normal cell to a malignant cell
• Recognize the malignant phenotype as the result of a characteristic pattern of gene expression, alterations in the function of the human genome, which cause erratic growth, dedifferentiation, invasion, and metastasis
• Characterize the different genes involved in cell cycle regulation (growth-promoting genes, growth-inhibiting genes, genes that regulate apoptosis and genes that repair damaged DNA), and the mutations that alter them
• Explain the key role that oncogenes may play in the development of cancer by directing mechanisms that lead to the development of neoplasms
• Know tumor suppressor genes as cytoplasmic components capable of reversing the tumor phenotype; proteins that control the cell cycle, proliferation, and differentiation
• Identify epigenetic aberrations (DNA methylation with silencing of gene expression, and histone modifications that can enhance or dampen expression), which contribute to the malignant properties of cells
• Recognize the role of epigenetic changes in malignant phenotype, including gene expression, control of differentiation, and sensitivity and resistance to anticancer therapy
• Know the genes and proteins associated with malignant diseases and their utility as tumor markers to define a particular entity, its diagnosis, staging, prognosis, and screening in the population
• Know and apply the different technologies used to analyze the gene expression profile of neoplasms to identify clinical and biological aspects that are difficult to determine by histopathological examination. Its principles, advantages, and disadvantages
• Explain the importance of gene expression profiling for the application of different treatment protocols and the response to them among histologically similar tumors
• Recognize the importance of gene expression profiling in the new classifications of malignant tumors associated with prognosis and response to treatment
• Know the differences between CNS tumors in children and adults
• Study the importance of routine, special, and biomarker stains in Medulloblastoma
• Learn about the advances in the diagnosis of CNS embryonal tumors in pediatrics
• Acquire in-depth knowledge of the diagnosis and management of CNS pseudotumoral lesions in children
• Acquire more in-depth knowledge of histological and molecular aspects of the adult CNS tumors with greater prevalence and clinical significance
• Acquire in-depth knowledge of the current diagnostic approach suggested by WHO and the CIMPACT-NOW consortium for the study of central nervous system tumors
• Acquire up-to-date knowledge of the morphological, molecular, and radiological diagnosis of sellar and suprasellar lesions
• Study of phenotypic expression patterns and molecular pathways involved in carcinogenesis
• Gain in-depth knowledge of the causes and molecular and cellular mechanisms involved in pathophysiology
• Acquire an integrative vision in the diagnosis of neoplastic disease
• Review of developments in the histopathologic classification of ovarian, vulvar, and uterine tumors

Take the opportunity and take the step to get up to date on the latest developments in Child and Juvenile Cancer"